PHARMANAUS

PHARMANAUS has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €633,235 and a net result of -€10,886. Equity remains stable across the filed financial years (±1.1% per year). Its solvency ranks better than 68% of 22,554 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).